CAM
TPTX
Cormorant Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,484,220
| Closed | -$187M | – | 86 |
|
|
2022
Q2 | $187M | Sell |
2,484,220
-1,215,780
| -33% | -$91.5M | 14.13% | 1 |
|
|
2022
Q1 | $99.3M | Buy |
3,700,000
+675,000
| +22% | +$18.1M | 7.63% | 1 |
|
|
2021
Q4 | $144M | Buy |
3,025,000
+182,703
| +6% | +$8.71M | 8.58% | 2 |
|
|
2021
Q3 | $189M | Sell |
2,842,297
-194,745
| -6% | -$12.9M | 7.67% | 2 |
|
|
2021
Q2 | $237M | Buy |
3,037,042
+287,042
| +10% | +$22.4M | 8.05% | 1 |
|
|
2021
Q1 | $260M | Buy |
2,750,000
+357,703
| +15% | +$33.8M | 5.8% | 2 |
|
|
2020
Q4 | $292M | Sell |
2,392,297
-50,000
| -2% | -$6.09M | 6.94% | 1 |
|
|
2020
Q3 | $213M | Sell |
2,442,297
-295,000
| -11% | -$25.8M | 8.2% | 1 |
|
|
2020
Q2 | $177M | Sell |
2,737,297
-319,500
| -10% | -$20.6M | 6.75% | 1 |
|
|
2020
Q1 | $137M | Sell |
3,056,797
-339,853
| -10% | -$15.2M | 6.34% | 1 |
|
|
2019
Q4 | $212M | Sell |
3,396,650
-144,717
| -4% | -$9.01M | 8.44% | 1 |
|
|
2019
Q3 | $133M | Buy |
3,541,367
+419,000
| +13% | +$15.8M | 8.11% | 1 |
|
|
2019
Q2 | $127M | Buy |
+3,122,367
| New | +$127M | 7.3% | 1 |
|